Determinants of coronary artery disease in nondiabetic hemodialysis patients: a matched case-control study

Aysegul Zumrutdal1, Mehmet Baltali, Hasan Micozkadioglu

  • 1Department of Nephrology, Baskent University Faculty of Medicine, Ankara, Turkey. azumrutdal@yahoo.com

Renal Failure
|March 17, 2007
PubMed

Insights

In nondiabetic hemodialysis patients, elevated high-sensitivity C-reactive protein (hs-CRP) and troponin I, along with low HDL cholesterol, are key indicators of coronary artery disease (CAD). These factors independently predict CAD risk in this vulnerable population.

Area of Science:

  • Nephrology
  • Cardiology
  • Clinical Chemistry

Background:

  • Coronary artery disease (CAD) is a significant concern in patients undergoing hemodialysis (HD).
  • Conventional risk factors may not fully explain CAD development in this population, necessitating investigation into other determinants.
  • Nondiabetic HD patients represent a specific subgroup where non-traditional risk factors for CAD require evaluation.

Purpose of the Study:

  • To identify determinants of coronary artery disease (CAD) beyond conventional risk factors in nondiabetic patients on regular hemodialysis (HD).
  • To compare specific biomarkers and clinical parameters between HD patients with and without angiographically defined CAD.

Main Methods:

  • A matched case-control study was conducted involving 26 nondiabetic HD patients with CAD (cases) and a control group matched for gender, smoking status, hypertension, age, and BMI.
  • Data collected included demographics, high-sensitivity C-reactive protein (hs-CRP), erythrocyte sedimentation rate (ESR), beta-2 microglobulin, cardiac troponin I, parathyroid hormone, albumin, calcium, phosphorus, and lipid profiles.
  • Statistical analysis, including backwards stepwise logistic regression, was used to determine independent predictors of CAD.

Main Results:

  • Patients with CAD exhibited significantly higher levels of hs-CRP and troponin I compared to controls.
  • Lower levels of HDL cholesterol were observed in the CAD group.
  • Logistic regression analysis identified high hs-CRP, high troponin I, and low HDL cholesterol as independent determinants of CAD.

Conclusions:

  • Elevated hs-CRP and troponin I levels are significant determinants of CAD in nondiabetic hemodialysis patients.
  • Low HDL cholesterol is also independently associated with the presence of CAD in this population.
  • These findings highlight the importance of monitoring these specific markers for CAD risk assessment in nondiabetic HD patients.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...